Clinical Trial Update: Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Ivonescimab alone and in combination with carboplatin/pemetrexed for non-small cell lung cancer, currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Ivonescimab (AK112/SMT112)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lung Cancer (NSCLC), Lung Cancer Non-Small Cell Cancer (NSCLC) | Phase 2 | Status: NOT_YET_RECRUITING